Features
Matt Fellows explores medical and pharmaceutical opinion of the divisive institute to determine whether it is the fit-for-purpose appraisal...
Paul Ranson, of global law firm Morgan Lewis' London Life Sciences Practice examines how UK biopharma must now adapt to a changing landscape
With the issue of transparency in the pharmaceutical industry on the lips of everyone from patients and physicians to US presidential candidates,...
With clinical trials becoming increasingly unfeasible as financial costs and time expenses rise, Matt Fellows investigates how cloud computing may...
It made headlines last week as a judge ruled that the treatment could be funded by the NHS, but some have labelled it simply a “lifestyle drug”....
The outcome of the popular vote cast on 23 June 2016 will be remembered as the start of a new era in the history of UK-EU relations.
A battle is raging for the soul of the pharma industry and the stakes are high.
Here’s a quick look at some of the biggest movers of the week:
Here’s a quick look at some of the biggest movers of the week:
Here’s a quick look at some of the biggest movers of the week:
